Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Express Scripts
Baxter
Harvard Business School
Daiichi Sankyo
UBS
Healthtrust
Moodys
Queensland Health
US Army

Generated: October 20, 2017

DrugPatentWatch Database Preview

Apothecon Company Profile

« Back to Dashboard

What is the competitive landscape for APOTHECON, and what generic and branded alternatives to APOTHECON drugs are available?

APOTHECON has one hundred and fourteen approved drugs.

There are three tentative approvals on APOTHECON drugs.

Summary for Applicant: Apothecon

US Patents:0
Tradenames:77
Ingredients:47
NDAs:114
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apothecon
DICLOXACILLIN SODIUM
dicloxacillin sodium
FOR SUSPENSION;ORAL061455-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Apothecon
CAPOZIDE 50/15
captopril; hydrochlorothiazide
TABLET;ORAL018709-004Oct 12, 1984DISCNYesNo► Subscribe► Subscribe► Subscribe
Apothecon
DILTIAZEM HYDROCHLORIDE
diltiazem hydrochloride
TABLET;ORAL074051-002Mar 31, 1993DISCNNoNo► Subscribe► Subscribe► Subscribe
Apothecon
CEPHALEXIN
cephalexin
CAPSULE;ORAL063186-002Dec 30, 1994DISCNNoNo► Subscribe► Subscribe► Subscribe
Apothecon
VELOSEF
cephradine
INJECTABLE;INJECTION061976-004Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Apothecon
TRIMOX
amoxicillin
FOR SUSPENSION;ORAL061886-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Apothecon
TRIMOX
amoxicillin
CAPSULE;ORAL062152-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Apothecon
PRINCIPEN
ampicillin/ampicillin trihydrate
FOR SUSPENSION;ORAL061394-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Apothecon
VESPRIN
triflupromazine hydrochloride
INJECTABLE;INJECTION011325-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Apothecon
OXACILLIN SODIUM
oxacillin sodium
CAPSULE;ORAL061450-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts
McKesson
Mallinckrodt
Daiichi Sankyo
Chubb
Healthtrust
Boehringer Ingelheim
Covington
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot